The information provided by the previous literature searches and meta-analyses illustrates that the field of sepsis biomarker research is very active, with certain traditionally established biomarkers such as CRP and PCT being evaluated alongside newer emerging biomarkers such as CD64, presepsin and sTREM-1. The gene discussed is CRP; the disease is Sepsis.